Anika Therapeutics, Inc. splits its revenue into 6 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was OEM Channel at $64.4 million, 57% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
FY 2016
Dec 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
121
|
113
|
120
|
121
|
114
|
148
|
130
|
115
|
106
|
113
|
103
|
| OA Pain Management |
—
|
—
|
—
|
102
+10.8%
share 84.4%
|
92
+8.1%
share 80.8%
|
85
+2.5%
share 57.6%
|
83
-19.8%
share 63.6%
|
103
share 90.3%
|
—
|
—
|
—
|
| OEM Channel |
69
-2.5%
share 57.1%
|
64
-17.2%
share 57.1%
|
78
-8.1%
share 64.9%
|
85
+3.6%
share 70.1%
|
82
share 71.8%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Joint Preservation And Restoration |
—
|
—
|
—
|
55
+8.9%
share 45.4%
|
50
+3.7%
share 44.3%
|
49
+23.4%
share 32.9%
|
39
+1801.8%
share 30.2%
|
2
share 1.8%
|
—
|
—
|
—
|
| Commercial Channel |
52
+18.0%
share 42.9%
|
48
+14.9%
share 42.9%
|
42
+16.6%
share 35.1%
|
36
+12.4%
share 29.9%
|
32
share 28.2%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Nonorthopedic |
—
|
—
|
—
|
10
-28.8%
share 8.2%
|
14
-1.9%
share 12.2%
|
14
+75.2%
share 9.6%
|
8
-10.2%
share 6.2%
|
9
share 7.8%
|
—
|
—
|
—
|
| Licensing Milestone And Contract Revenue |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
0
share 0.1%
|
—
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ANIK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bedford, MA
- SEC filer status
- Accelerated filer
- SEC CIK
- 898437
- Former names
- ANIKA THERAPEUTICS INC (until Mar 13, 2014); ANIKA RESEARCH INC (until Nov 27, 1996)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.